SRRK Stock Analysis: Buy, Sell, or Hold?
SRRK - Scholar Rock Holding Corporation Common Stock
$46.61
2.27 (5.12%)
▲
5d:
+3.83%
30d:
+5.81%
90d:
+58.7%
BUY
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Feb 26, 2026
22d
Get Alerted When SRRK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SRRK shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: SRRK shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SRRK is currently trading at $46.61, which is considered extended relative to its 30-day fair value range of $42.81 to $45.88.
Technical Outlook: Technically, SRRK is in a strong uptrend. Immediate support is located at $42.87, while resistance sits at $48.28. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SRRK is in a strong uptrend. Immediate support is located at $42.87, while resistance sits at $48.28. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$42.81 -
$45.88
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.3%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.1%)
- NEUTRAL: Near Wall St target ($50.36)
Fair Price Analysis
30-Day Fair Range
$42.81 -
$45.88
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$3.86
(8.3%)
Support & Resistance Levels
Support Level
$42.87
Resistance Level
$48.28
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-15.67
Wall Street Target
$50.36
(+8.0%)
Revenue Growth (YoY)
-100.0%
Last updated: February 02, 2026 7:41 PM ET
Data refreshes hourly during market hours. Next update: 8:41 PM
Data refreshes hourly during market hours. Next update: 8:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRRK showing a specific setup today?
Insider Activity (6 Months)
2
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Srinivas Akkaraju
BUY
113025 shares
2025-10-06
Srinivas Akkaraju
BUY
387414 shares
2025-10-03
Mo Qatanani
SELL
3353 shares
2025-09-22
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 61 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 51 HOLD |
Advanced SRRK Option Strategies
Professional options setups generated by AI based on today's SRRK price and gamma walls.
